Mirae Asset Global ETFs Holdings’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
SCM
Mirae Asset Global ETFs Holdings's ORGO Position: Q2 2026 in Review
Mirae Asset Global ETFs Holdings reduced its Organogenesis Holdings (ORGO) stake by 1.9% in Q2 2026, selling an estimated $1.54K and leaving 31,852 shares worth $77.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2929.
Mirae Asset Global ETFs Holdings first reported a position in ORGO in Q2 2024 and has held it in 9 quarters since. The position peaked at $183K in Q1 2025. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.
- Mirae Asset Global ETFs Holdings held 31,852 shares of Organogenesis Holdings worth $77.4K as of Q2 2026.
- Mirae Asset Global ETFs Holdings sold 630 Organogenesis Holdings shares in Q2 2026, an estimated $1.54K.
- Organogenesis Holdings made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2929 holding.
- Mirae Asset Global ETFs Holdings first reported a position in Organogenesis Holdings in Q2 2024 and has held it in 9 quarters since.
- Mirae Asset Global ETFs Holdings's Organogenesis Holdings position peaked at $183K in Q1 2025.
- 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.
Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.